COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
Clinical trial NCT04476953 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04476953
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2026-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.